Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Brandi Bloch

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Acta Ophthalmologica|November 12, 2013
Implementation studies of ranibizumab for neovascular age-related macular degenerationSara Brandi Bloch
Ugeskrift for Laeger|November 21, 2009
[Treatment of wet age-related macular degeneration with vascular endothelial growth factor. A survey of a Cochrane review]Sara Brandi Bloch, Michael Larsen
Acta Ophthalmologica|February 18, 2015
Translational public health care perspective: intravitreal treatment of neovascular age-related macular degeneration has revolutionized clinical ophthalmologySara Brandi Bloch, Michael Larsen
American Journal of Ophthalmology|January 24, 2012
Incidence of legal blindness from age-related macular degeneration in denmark: year 2000 to 2010Sara Brandi Bloch, Michael Larsen, Inger Christine Munch
American Journal of Ophthalmology|May 14, 2013
Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumabSara Brandi Bloch, Henrik Lund-Andersen, Birgit Sander, et al.
Ugeskrift for Laeger|April 10, 2008
[New treatment of age-related macular degeneration. The Danish Society of Ophthalmology]Sara Brandi Bloch, Michael Larsen, Per Haamann, et al.
Acta Ophthalmologica|November 25, 2010
Contraction of occult choroidal neovascular membrane and rupture of the retinal pigment following verteporfin and bevacizumab treatmentSara Brandi Bloch, Ahmed Bedda, Ahmed M Abdel Hadi, et al.
Ugeskrift for Laeger|June 7, 2008
[Central serous chorioretinopathy]Sara Brandi Bloch, Mette-Marie Orebo Hansen, Per Haamann, et al.
Acta Ophthalmologica|November 19, 2014
Safety study of 38,503 intravitreal ranibizumab injections performed mainly by physicians in training and nurses in a hospital settingPascal W Hasler, Sara Brandi Bloch, Jørgen Villumsen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Acta Ophthalmologica|November 12, 2013
Implementation studies of ranibizumab for neovascular age-related macular degenerationSara Brandi Bloch
Ugeskrift for Laeger|November 21, 2009
[Treatment of wet age-related macular degeneration with vascular endothelial growth factor. A survey of a Cochrane review]Sara Brandi Bloch, Michael Larsen
Acta Ophthalmologica|February 18, 2015
Translational public health care perspective: intravitreal treatment of neovascular age-related macular degeneration has revolutionized clinical ophthalmologySara Brandi Bloch, Michael Larsen
American Journal of Ophthalmology|January 24, 2012
Incidence of legal blindness from age-related macular degeneration in denmark: year 2000 to 2010Sara Brandi Bloch, Michael Larsen, Inger Christine Munch
American Journal of Ophthalmology|May 14, 2013
Subfoveal fibrosis in eyes with neovascular age-related macular degeneration treated with intravitreal ranibizumabSara Brandi Bloch, Henrik Lund-Andersen, Birgit Sander, et al.
Ugeskrift for Laeger|April 10, 2008
[New treatment of age-related macular degeneration. The Danish Society of Ophthalmology]Sara Brandi Bloch, Michael Larsen, Per Haamann, et al.
Acta Ophthalmologica|November 25, 2010
Contraction of occult choroidal neovascular membrane and rupture of the retinal pigment following verteporfin and bevacizumab treatmentSara Brandi Bloch, Ahmed Bedda, Ahmed M Abdel Hadi, et al.
Ugeskrift for Laeger|June 7, 2008
[Central serous chorioretinopathy]Sara Brandi Bloch, Mette-Marie Orebo Hansen, Per Haamann, et al.
Acta Ophthalmologica|November 19, 2014
Safety study of 38,503 intravitreal ranibizumab injections performed mainly by physicians in training and nurses in a hospital settingPascal W Hasler, Sara Brandi Bloch, Jørgen Villumsen, et al.
Pageof 1